Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Its FDA approval underscores its safety and efficacy as a weight-loss treatment
If your fitness goals or side effect profile change, talk with your prescribing provider about dose adjustments or alternative GLP-1 options
Four patients (6.90%) were taking no ASMs, 11 patients (18.96%) were on monotherapy with one ASM, while 43 patients (74.14%) were on polytherapy of two or more ASMs
The benzyl alcohol remains effective, but the cumulative risk from repeated access makes continued use unsafe after 28 days
Marbury TC, Flint A, Jacobsen JB, Karsbl JD, Lasseter K
The Certificate of Analysis (COA) for this product is available for download: View COA / HPLC / MS Report
US$ 22.22
US$ 28.48
US$ 22.76
US$ 29.65
